If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.685    0.065 (1.41%)
Bid:
4.70
Ask:
4.725
Spread: 0.025 (0.532%)
Market Cap: £224.86m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Implementation of Long Term Incentive Plan

5 Sep 2013 11:30

RNS Number : 3177N
Seeing Machines Limited
05 September 2013
 

 

 

Seeing Machines Limited

("Seeing Machines" or the "Company")

 

IMPLEMENTATION OF NEW LONG TERM INCENTIVE PLAN FOR EXECUTIVES AND

ISSUE OF EQUITY

 

Seeing Machines Limited (AIM: SEE), the AIM-listed technology company with a focus on vision based human machine interfaces,announces today the implementation of a significant Long Term Incentive Plan ("LTIP") for senior executives. Having put a quality management team in place, Seeing Machines wishes to incentivise and retain them.

 

Accordingly, the Company announces that the first round of 15,290,020 new fully paid ordinary shares of no par value ("New Ordinary Shares") have been allocated in varying numbers to the trustee of the Loan Plan on trust for 10 executives (including the CEO and CFO). These shares will not vest for the benefit of executives

(i) until 1 July 2016 (subject to a small number of extraordinary events occurring) and

(ii) unless the executives remain with the Company for more than 3 years and

(iii) unless the Company's share price meets or exceeds a 'stretch target'.

 

Should these requirements be met, Seeing Machines will provide a non-recourse, interest-free loan to enable the executives to purchase their allocated shares at a price set at the beginning of the 3 year period. The shares issued under the LTIP, which have been subscribed for by way of Company loans to the trust, have been issued at a price of 2 pence per share for Ken Kroeger and one other, and at a price of 3 pence per share for 8 other executives. Under the LTIP, the issue price is set in July each year based on the average of the trading price for the 30 days preceding 30 June.

 

The Company also announces that it has today issued 1,345,227 New Ordinary Shares to a Director, former Directors and present and former senior executives under the 'Old' Executive Share Plan ("ESP") (terminated on 30 June 2013) and 4,453,036 New Ordinary Shares under an agreement reached between the Company and three senior sales people to convert their after-tax bonuses into shares. The shares issued under the 'Old' ESP are based on a salary/fee sacrifice arrangement and have been issued at a price of 2.4 pence per share.

 

Under the 'payment of bonuses' arrangement, some shares were issued at 2 pence per share and some at 2.75 pence per share.

 

Under the Old ESP (in the case of David Gaul) and the LTIP (in the case of Ken Kroeger), the Directors are now interested in shares as follows:

Director

Ordinary Shares awarded

Holding following award of Ordinary Shares

Percentage holding following award of Ordinary Shares

David Gaul1

113,850

3,466,978

0.69%

Ken Kroeger2

5,606,250

7,198,607

1.43%

1. David Gaul's shares are held in the name of Jaiclimb Pty Ltd.

2. Ken Kroeger's interest in shares is held in the name of Insperience Pty Ltd.

 

 

Application has been made for the 21,718,285 New Ordinary Shares to be admitted to trading on AIM. It is expected that admission will occur on 6 September 2013. Immediately following the admission of the New Ordinary Shares, the Company will have 502,226,253 ordinary shares in issue.

 

Enquiries:

 

Seeing Machines Limited

Ken Kroeger, Managing Director and CEO

+61 2 6103 4700

Ken.Kroeger@seeingmachines.com

Terry Winters, Chairman

+61 2 6103 4700

Terry.Winters@seeingmachines.com

 

finnCap Limited

 

 

Ed Frisby / Ben Thompson, Corporate Finance

+44 20 7220 0500

Simon Starr, Corporate Broking

 

 

 

AxiCom Limited

James Kennedy

 

+44 20 8392 4091

James.kennedy@axicom.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUVARROBAKRAR
Date   Source Headline
7th Aug 20097:00 amRNSAppointment of broker
11th Jun 20099:12 amRNSDirector/PDMR Shareholding
21st May 20097:58 amRNSDirector Shareholding
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.